Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 2Psoriasis 1Plaque, Amyloid 1Dermatitis, Atopic 1

Interventions

tofacitinib 7Etanercept 7Methotrexate 4Adalimumab 4deucravacitinib 3secukinumab 2apremilast 2Nivolumab 2sotrastaurin 1sodium luminolate 1purine 1ixekizumab 1fumaric acid 1calcipotriene 1cabozantinib 1baricitinib 1abrocitinib 1Vitamin D 1Vaccines 1Sulfasalazine 1Standard of Care 1Specimen Handling 1Saline Solution 1Practice Guidelines as Topic 1Platinum Compounds 1Methods 1Mesalamine 1Mercaptopurine 1Ipilimumab 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × abrocitinib × Clear all
NCT02201524 2016-10-05

Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis

Pfizer

Phase 2 Terminated
59 enrolled 18 charts
Lymphoid

Lymphoma, Follicular, Psoriasis, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡